Overview
Our team is primarily focused on clinical research in adolescent girls and women with bleeding disorders and in conducting clinical trials focused on hemophilia A with and without inhibitors. Our institution created the Atlanta Protocol which combines FVIII ITI with Hemlibra and this is under investigation in clinical trials.
Current Projects
- MOTIVATE Study (co-PI), NCT04023019
- ATHN 9: Severe VWD Study (co-PI), NCT03853486
- SAFE Study (PI), NCT04563520